Symbols / KRMD Stock $3.88 -1.52% KORU Medical Systems, Inc.

Healthcare • Medical Instruments & Supplies • United States • NCM
KRMD (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Ms. Linda M. Tharby
Exch · Country NCM · United States
Market Cap 178.22M
Enterprise Value 175.57M
Income -2.28M
Sales 43.26M
FCF (ttm) 874.28K
Book/sh 0.37
Cash/sh 0.19
Employees 73
Insider 10d —
IPO Apr 05, 1994
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E 48.50
PEG —
P/S 4.12
P/B 10.57
P/C —
EV/EBITDA -91.47
EV/Sales 4.06
Quick Ratio 1.70
Current Ratio 2.33
Debt/Eq 19.89
LT Debt/Eq —
EPS (ttm) -0.05
EPS next Y 0.08
EPS Growth —
Revenue Growth 22.10%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-06
ROA -5.81%
ROE -13.70%
ROIC —
Gross Margin 61.93%
Oper. Margin -7.35%
Profit Margin -5.27%
Shs Outstand 45.93M
Shs Float 28.34M
Insider Own 7.96%
Instit Own 57.09%
Short Float 1.93%
Short Ratio 5.49
Short Interest 724.76K
52W High 6.61
vs 52W High -41.28%
52W Low 2.91
vs 52W Low 33.33%
Beta 0.42
Impl. Vol. 22.63%
Rel Volume 0.71
Avg Volume 128.00K
Volume 91.13K
Target (mean) $6.80
Tgt Median $7.00
Tgt Low $5.00
Tgt High $8.00
# Analysts 5
Recom None
Prev Close $3.94
Price $3.88
Change -1.52%
About

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.80
Mean price target
2. Current target
$3.88
Latest analyst target
3. DCF / Fair value
$0.34
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.88
Low
$5.00
High
$8.00
Mean
$6.80

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-13 main Canaccord Genuity Buy → Buy $6
2026-03-13 main B. Riley Securities Buy → Buy $8
2025-12-22 main Lake Street Buy → Buy $8
2025-12-17 main Canaccord Genuity Buy → Buy $6
2025-08-07 main Piper Sandler Neutral → Neutral $4
2025-05-08 main Piper Sandler Neutral → Neutral $4
2025-02-14 down Piper Sandler Overweight → Neutral $5
2025-01-17 main Craig-Hallum Buy → Buy $6
2025-01-14 main Lake Street Buy → Buy $5
2024-11-14 main Craig-Hallum Buy → Buy $5
2024-11-14 main Canaccord Genuity Buy → Buy $4
2024-11-14 main Piper Sandler Overweight → Overweight $4
2024-08-08 main Piper Sandler Overweight → Overweight $3
2024-03-14 reit B. Riley Securities Buy → Buy $4
2023-12-07 reit Canaccord Genuity Buy → Buy $3
2023-09-07 init Lake Street — → Buy $4
2023-09-07 init B. Riley Securities — → Buy $5
2023-08-03 main Piper Sandler Overweight → Overweight $3
2023-01-06 main Piper Sandler — → Overweight $5
2022-11-10 up Canaccord Genuity Hold → Buy $4
News
RSS: Latest KRMD news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-11 KALBERMATTEN ADAM R President — 12,500 $3.93 $49,275
2026-05-18 SCHILLER ERIC Chief Technology Officer — 5,000 $3.91 $19,562
2026-05-15 THARBY LINDA M Chief Executive Officer — 1,191 $3.90 $4,645
2026-05-15 THARBY LINDA M Chief Executive Officer — 1,191 $3.92 $4,669
2026-05-14 PAZDAN CHRISTOPHER Chief Operating Officer — 5,327 — —
2026-05-14 ADAMS THOMAS EDWARD Chief Financial Officer — 8,193 — —
2026-05-14 THARBY LINDA M Chief Executive Officer — 13,977 — —
2026-05-14 ADAMS THOMAS EDWARD Chief Financial Officer — 5,500 $3.86 $21,248
2026-05-14 PAZDAN CHRISTOPHER Chief Operating Officer — 5,000 $3.88 $19,400
2026-04-01 FLETCHER R JOHN Chairman of the Board — 5,208 $4.32 $22,499
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
41.13
+22.23%
33.65
+17.98%
28.52
+2.23%
27.90
Operating Revenue
41.13
+22.23%
33.65
+17.98%
28.52
+2.23%
27.90
Cost Of Revenue
15.52
+26.06%
12.31
+4.28%
11.81
-5.73%
12.53
Reconciled Cost Of Revenue
15.52
+26.06%
12.31
+4.28%
11.81
-5.73%
12.53
Gross Profit
25.60
+20.03%
21.33
+27.67%
16.71
+8.71%
15.37
Operating Expense
28.58
+2.87%
27.78
+2.96%
26.98
+3.17%
26.15
Research And Development
4.39
-16.56%
5.26
-8.43%
5.74
+15.86%
4.96
Selling General And Administration
23.38
+8.08%
21.63
+6.22%
20.37
-1.17%
20.61
Total Expenses
44.10
+9.99%
40.09
+3.36%
38.79
+0.29%
38.68
Operating Income
-2.97
+53.89%
-6.45
+37.23%
-10.27
+4.74%
-10.78
Total Operating Income As Reported
-2.97
+53.89%
-6.45
+37.23%
-10.27
+4.74%
-10.78
EBITDA
-2.16
+61.10%
-5.56
+40.87%
-9.40
+7.79%
-10.19
Normalized EBITDA
-2.22
+59.81%
-5.51
+40.95%
-9.33
+8.07%
-10.15
Reconciled Depreciation
0.81
-8.78%
0.89
+2.08%
0.87
+48.24%
0.59
EBIT
-2.97
+53.89%
-6.45
+37.23%
-10.27
+4.74%
-10.78
Total Unusual Items
0.05
+215.45%
-0.05
+29.17%
-0.06
-62.84%
-0.04
Total Unusual Items Excluding Goodwill
0.05
+215.45%
-0.05
+29.17%
-0.06
-62.84%
-0.04
Special Income Charges
—
-0.02
+72.98%
-0.06
0.00
Net Income
-2.64
+56.52%
-6.07
+55.85%
-13.74
-58.65%
-8.66
Pretax Income
-2.62
+56.86%
-6.06
+37.96%
-9.77
+8.45%
-10.68
Net Non Operating Interest Income Expense
0.29
-34.01%
0.44
-20.79%
0.56
+285.56%
0.15
Net Interest Income
0.29
-34.01%
0.44
-20.79%
0.56
+285.56%
0.15
Interest Income Non Operating
0.29
-34.01%
0.44
-20.79%
0.56
+285.56%
0.15
Interest Income
0.29
-34.01%
0.44
-20.79%
0.56
+285.56%
0.15
Other Income Expense
0.06
+201.37%
-0.06
+4.28%
-0.06
-62.84%
-0.04
Other Non Operating Income Expenses
0.01
+161.30%
-0.02
—
—
Gain On Sale Of Security
0.05
+215.45%
-0.05
-797.56%
-0.01
+87.15%
-0.04
Tax Provision
0.02
+656.65%
0.00
-99.93%
3.97
+296.99%
-2.01
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+11.31%
0.00
Tax Effect Of Unusual Items
0.01
+215.45%
-0.01
+29.17%
-0.01
-81.26%
-0.01
Net Income Including Noncontrolling Interests
-2.64
+56.52%
-6.07
+55.85%
-13.74
-58.65%
-8.66
Net Income From Continuing Operation Net Minority Interest
-2.64
+56.52%
-6.07
+55.85%
-13.74
-58.65%
-8.66
Net Income From Continuing And Discontinued Operation
-2.64
+56.52%
-6.07
+55.85%
-13.74
-58.65%
-8.66
Net Income Continuous Operations
-2.64
+56.52%
-6.07
+55.85%
-13.74
-58.65%
-8.66
Normalized Income
-2.68
+55.56%
-6.03
+55.95%
-13.69
-58.65%
-8.63
Net Income Common Stockholders
-2.64
+56.52%
-6.07
+55.85%
-13.74
-58.65%
-8.66
Diluted EPS
-0.06
+53.85%
-0.13
+56.67%
-0.30
-57.89%
-0.19
Basic EPS
-0.06
+53.85%
-0.13
+56.67%
-0.30
-57.89%
-0.19
Basic Average Shares
46.19
+0.84%
45.80
+0.44%
45.60
+1.33%
45.00
Diluted Average Shares
46.19
+0.84%
45.80
+0.44%
45.60
+1.33%
45.00
Diluted NI Availto Com Stockholders
-2.64
+56.52%
-6.07
+55.85%
-13.74
-58.65%
-8.66
Depreciation Amortization Depletion Income Statement
0.81
-8.78%
0.89
+2.08%
0.87
+48.24%
0.59
Depreciation And Amortization In Income Statement
0.81
-8.78%
0.89
+2.08%
0.87
+48.24%
0.59
Gain On Sale Of PPE
—
-0.02
+72.98%
-0.06
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
28.20
+3.61%
27.22
-4.37%
28.46
-32.77%
42.33
Current Assets
19.99
+4.48%
19.13
-5.55%
20.26
-32.03%
29.80
Cash Cash Equivalents And Short Term Investments
8.87
-7.40%
9.58
-16.56%
11.48
-34.04%
17.41
Cash And Cash Equivalents
8.87
-7.40%
9.58
-16.56%
11.48
-34.04%
17.41
Receivables
6.53
+8.87%
6.00
+47.22%
4.07
-10.09%
4.53
Accounts Receivable
5.89
+7.13%
5.50
+35.92%
4.05
+13.67%
3.56
Gross Accounts Receivable
—
—
4.07
+13.68%
3.58
Allowance For Doubtful Accounts Receivable
—
—
-0.02
-15.46%
-0.02
Other Receivables
0.64
+28.03%
0.50
+1630.13%
0.03
-97.03%
0.97
Inventory
3.68
+31.19%
2.80
-19.46%
3.48
-45.65%
6.40
Raw Materials
0.73
-11.51%
0.83
-55.72%
1.87
-51.48%
3.85
Finished Goods
2.95
+48.98%
1.98
+6.30%
1.86
-28.69%
2.61
Prepaid Assets
—
—
—
1.46
Other Current Assets
0.91
+21.16%
0.75
-38.45%
1.22
-16.40%
1.46
Total Non Current Assets
8.21
+1.55%
8.09
-1.45%
8.21
-34.52%
12.53
Net PPE
7.43
+2.35%
7.26
-1.29%
7.35
-4.19%
7.67
Gross PPE
11.49
+7.13%
10.73
+6.52%
10.07
-3.77%
10.47
Accumulated Depreciation
-4.07
-17.11%
-3.47
-27.62%
-2.72
+2.62%
-2.79
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.41
-1.81%
1.43
+1.52%
1.41
-3.06%
1.46
Other Properties
8.13
+10.70%
7.34
+9.47%
6.71
+1.66%
6.60
Leases
1.96
+0.28%
1.95
+0.00%
1.95
-19.06%
2.41
Goodwill And Other Intangible Assets
0.68
-6.22%
0.73
-3.19%
0.75
-4.17%
0.79
Non Current Deferred Assets
—
—
0.00
-100.00%
3.97
Non Current Deferred Taxes Assets
—
—
0.00
-100.00%
3.97
Other Non Current Assets
0.10
+0.00%
0.10
+0.00%
0.10
-3.56%
0.10
Total Liabilities Net Minority Interest
11.15
+7.18%
10.40
+28.34%
8.11
-26.34%
11.01
Current Liabilities
8.19
+13.78%
7.20
+61.68%
4.45
-35.99%
6.96
Payables And Accrued Expenses
7.63
+19.46%
6.39
+102.74%
3.15
-45.92%
5.82
Payables
2.27
+37.43%
1.65
+69.19%
0.98
-59.23%
2.39
Accounts Payable
2.27
+37.43%
1.65
+69.19%
0.98
-59.23%
2.39
Current Accrued Expenses
5.36
+13.20%
4.74
+117.79%
2.17
-36.65%
3.43
Current Debt And Capital Lease Obligation
0.54
-31.59%
0.79
-0.66%
0.79
-9.72%
0.88
Current Debt
—
0.27
-13.74%
0.31
-27.45%
0.43
Current Capital Lease Obligation
0.54
+4.36%
0.52
+7.95%
0.48
+7.58%
0.44
Current Deferred Liabilities
—
—
—
—
Current Deferred Revenue
—
—
—
—
Other Current Liabilities
0.03
-5.29%
0.03
-94.29%
0.51
+99.16%
0.26
Total Non Current Liabilities Net Minority Interest
2.96
-7.65%
3.20
-12.32%
3.65
-9.75%
4.05
Long Term Debt And Capital Lease Obligation
2.96
-7.65%
3.20
-12.32%
3.65
-9.75%
4.05
Long Term Capital Lease Obligation
2.96
-7.65%
3.20
-12.32%
3.65
-9.75%
4.05
Stockholders Equity
17.05
+1.39%
16.81
-17.39%
20.35
-35.03%
31.33
Common Stock Equity
17.05
+1.39%
16.81
-17.39%
20.35
-35.03%
31.33
Capital Stock
0.50
+0.84%
0.49
+0.59%
0.49
+0.47%
0.49
Common Stock
0.50
+0.84%
0.49
+0.59%
0.49
+0.47%
0.49
Share Issued
49.81
+0.84%
49.40
+0.62%
49.09
+0.47%
48.86
Ordinary Shares Number
46.37
+0.90%
45.96
+0.63%
45.67
+0.50%
45.44
Treasury Shares Number
3.44
+0.00%
3.44
+0.53%
3.42
+0.00%
3.42
Additional Paid In Capital
52.45
+5.78%
49.58
+5.45%
47.02
+6.25%
44.25
Retained Earnings
-32.02
-8.98%
-29.38
-26.02%
-23.31
-143.57%
-9.57
Treasury Stock
3.88
+0.00%
3.88
+1.01%
3.84
+0.00%
3.84
Total Equity Gross Minority Interest
17.05
+1.39%
16.81
-17.39%
20.35
-35.03%
31.33
Total Capitalization
17.05
+1.39%
16.81
-17.39%
20.35
-35.03%
31.33
Working Capital
11.79
-1.14%
11.93
-24.50%
15.80
-30.82%
22.84
Invested Capital
17.05
-0.22%
17.08
-17.34%
20.67
-34.92%
31.76
Total Debt
3.50
-12.37%
3.99
-10.24%
4.45
-9.74%
4.93
Capital Lease Obligations
3.50
-5.99%
3.72
-9.97%
4.13
-8.04%
4.49
Net Tangible Assets
16.36
+1.74%
16.08
-17.94%
19.60
-35.82%
30.54
Tangible Book Value
16.36
+1.74%
16.08
-17.94%
19.60
-35.82%
30.54
Current Notes Payable
0.00
-100.00%
0.27
-13.74%
0.31
-27.45%
0.43
Inventories Adjustments Allowances
-0.00
-0.85%
-0.00
+98.41%
-0.25
-316.81%
-0.06
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
0.46
+244.63%
-0.32
+93.47%
-4.89
+9.47%
-5.40
Cash Flow From Continuing Operating Activities
0.46
+244.63%
-0.32
+93.47%
-4.89
+9.47%
-5.40
Net Income From Continuing Operations
-2.64
+56.52%
-6.07
+55.85%
-13.74
-58.65%
-8.66
Depreciation Amortization Depletion
0.81
-8.78%
0.89
+2.08%
0.87
+48.24%
0.59
Depreciation And Amortization
0.81
-8.78%
0.89
+2.08%
0.87
+48.24%
0.59
Other Non Cash Items
-0.10
-140.20%
0.24
+1206.94%
-0.02
-110.35%
0.21
Stock Based Compensation
2.71
+3.42%
2.62
-5.23%
2.77
-10.08%
3.08
Provisionand Write Offof Assets
—
—
—
—
Deferred Tax
—
0.00
-100.00%
3.97
+295.81%
-2.03
Deferred Income Tax
—
0.00
-100.00%
3.97
+295.81%
-2.03
Operating Gains Losses
-0.01
-141.46%
0.02
-72.98%
0.06
—
Gain Loss On Sale Of PPE
-0.01
-141.46%
0.02
-72.98%
0.06
0.00
Change In Working Capital
-0.32
-116.16%
1.97
+64.04%
1.20
-14.23%
1.40
Change In Receivables
-0.49
+70.80%
-1.68
-466.49%
0.46
+307.64%
-0.22
Changes In Account Receivables
-0.49
+70.80%
-1.68
-244.53%
-0.49
-1530.29%
0.03
Change In Inventory
-0.87
-229.05%
0.68
-76.82%
2.92
+1079.32%
-0.30
Change In Prepaid Assets
-0.20
-189.35%
0.22
-9.26%
0.24
+743.06%
0.03
Change In Payables And Accrued Expense
1.24
-61.60%
3.24
+220.99%
-2.67
-254.93%
1.73
Change In Accrued Expense
0.63
-75.59%
2.56
+303.60%
-1.26
-323.83%
0.56
Change In Payable
0.62
-8.49%
0.67
+147.63%
-1.42
-221.67%
1.16
Change In Account Payable
0.62
-8.49%
0.67
+147.63%
-1.42
-221.67%
1.16
Change In Other Working Capital
—
—
—
0.17
Change In Other Current Liabilities
-0.00
+99.68%
-0.48
-289.37%
0.26
+52.50%
0.17
Investing Cash Flow
-0.95
+28.75%
-1.33
-63.64%
-0.81
+70.92%
-2.80
Cash Flow From Continuing Investing Activities
-0.95
+28.75%
-1.33
-63.64%
-0.81
+70.92%
-2.80
Net PPE Purchase And Sale
-0.93
+28.17%
-1.29
-64.62%
-0.78
+71.64%
-2.76
Purchase Of PPE
-0.93
+28.13%
-1.30
-65.71%
-0.78
+71.64%
-2.76
Sale Of PPE
0.01
-21.18%
0.01
0.00
0.00
Capital Expenditure
-0.96
+28.70%
-1.34
-64.69%
-0.81
+70.92%
-2.80
Net Intangibles Purchase And Sale
-0.02
+45.66%
-0.04
-39.39%
-0.03
+21.88%
-0.04
Purchase Of Intangibles
-0.02
+45.66%
-0.04
-39.39%
-0.03
+21.88%
-0.04
Financing Cash Flow
-0.22
+10.94%
-0.25
-13.55%
-0.22
-178.31%
0.28
Cash Flow From Continuing Financing Activities
-0.22
+10.94%
-0.25
-13.55%
-0.22
-178.31%
0.28
Net Issuance Payments Of Debt
-0.38
-151.39%
-0.15
+30.94%
-0.22
-72.15%
-0.13
Issuance Of Debt
0.41
-16.57%
0.49
-13.74%
0.57
-27.89%
0.78
Repayment Of Debt
-0.79
-23.18%
-0.64
+18.54%
-0.78
+13.93%
-0.91
Long Term Debt Issuance
0.41
-16.57%
0.49
-13.74%
0.57
-27.89%
0.78
Long Term Debt Payments
-0.79
-23.18%
-0.64
+18.54%
-0.78
+13.93%
-0.91
Net Long Term Debt Issuance
-0.38
-151.39%
-0.15
+30.94%
-0.22
-72.15%
-0.13
Short Term Debt Payments
—
—
—
-0.86
Net Short Term Debt Issuance
—
—
—
-0.86
Net Common Stock Issuance
—
—
0.00
-100.00%
0.41
Common Stock Payments
—
—
—
—
Repurchase Of Capital Stock
—
—
—
—
Proceeds From Stock Option Exercised
0.19
0.00
—
—
Net Other Financing Charges
-0.03
+71.72%
-0.10
-191.02%
-0.03
—
Changes In Cash
-0.71
+62.72%
-1.90
+67.92%
-5.93
+25.24%
-7.93
Beginning Cash Position
9.58
-16.56%
11.48
-34.04%
17.41
-31.29%
25.33
End Cash Position
8.87
-7.40%
9.58
-16.56%
11.48
-34.04%
17.41
Free Cash Flow
-0.49
+70.26%
-1.66
+70.89%
-5.71
+30.45%
-8.21
Interest Paid Supplemental Data
0.06
-22.78%
0.07
+41.51%
0.05
+78.42%
0.03
Income Tax Paid Supplemental Data
0.01
0.00
-100.00%
0.00
0.00
Change In Income Tax Payable
—
—
—
—
Change In Tax Payable
—
—
—
—
Common Stock Issuance
—
—
0.00
-100.00%
0.41
Issuance Of Capital Stock
—
—
0.00
-100.00%
0.41
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category